These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 21325726)
1. Role of peroxisome proliferator-activated receptor-γ in atherosclerosis: an update. Wang N; Yin R; Liu Y; Mao G; Xi F Circ J; 2011; 75(3):528-35. PubMed ID: 21325726 [TBL] [Abstract][Full Text] [Related]
3. Peroxisome Proliferator-Activated Receptor (PPAR) Gamma Agonists as Therapeutic Agents for Cardiovascular Disorders: Focus on Atherosclerosis. Ivanova EA; Myasoedova VA; Melnichenko AA; Orekhov AN Curr Pharm Des; 2017; 23(7):1119-1124. PubMed ID: 27855608 [TBL] [Abstract][Full Text] [Related]
4. Update on cardiovascular safety of PPARgamma agonists and relevance to medicinal chemistry and clinical pharmacology. Ciudin A; Hernandez C; Simó R Curr Top Med Chem; 2012; 12(6):585-604. PubMed ID: 22242856 [TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor-gamma in vascular biology. Li J; Wang N Cardiovasc Hematol Disord Drug Targets; 2007 Jun; 7(2):109-17. PubMed ID: 17584045 [TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammation. Belvisi MG; Hele DJ; Birrell MA Eur J Pharmacol; 2006 Mar; 533(1-3):101-9. PubMed ID: 16458290 [TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor gamma and the regulation of adipocyte function: lessons from human genetic studies. Gurnell M Best Pract Res Clin Endocrinol Metab; 2005 Dec; 19(4):501-23. PubMed ID: 16311214 [TBL] [Abstract][Full Text] [Related]
9. The many faces of PPARgamma. Lehrke M; Lazar MA Cell; 2005 Dec; 123(6):993-9. PubMed ID: 16360030 [TBL] [Abstract][Full Text] [Related]
10. Narrowing in on cardiovascular disease: the atheroprotective role of peroxisome proliferator-activated receptor gamma. Gerry JM; Pascual G Trends Cardiovasc Med; 2008 Feb; 18(2):39-44. PubMed ID: 18308193 [TBL] [Abstract][Full Text] [Related]
11. Inflammation in diabetes mellitus: role of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma agonists. Libby P; Plutzky J Am J Cardiol; 2007 Feb; 99(4A):27B-40B. PubMed ID: 17307056 [TBL] [Abstract][Full Text] [Related]
12. Metabolic and additional vascular effects of thiazolidinediones. Martens FM; Visseren FL; Lemay J; de Koning EJ; Rabelink TJ Drugs; 2002; 62(10):1463-80. PubMed ID: 12093315 [TBL] [Abstract][Full Text] [Related]
13. [PPAR receptors and insulin sensitivity: new agonists in development]. Pégorier JP Ann Endocrinol (Paris); 2005 Apr; 66(2 Pt 2):1S10-7. PubMed ID: 15959400 [TBL] [Abstract][Full Text] [Related]
15. Review: Peroxisome proliferator-activated receptor gamma and adipose tissue--understanding obesity-related changes in regulation of lipid and glucose metabolism. Sharma AM; Staels B J Clin Endocrinol Metab; 2007 Feb; 92(2):386-95. PubMed ID: 17148564 [TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor gamma as a novel therapeutic target in asthma. Park SJ; Lee YC J Asthma; 2008; 45(1):1-8. PubMed ID: 18259989 [TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor gamma agonists: their role as vasoprotective agents in diabetes. Blaschke F; Caglayan E; Hsueh WA Endocrinol Metab Clin North Am; 2006 Sep; 35(3):561-74, ix. PubMed ID: 16959586 [TBL] [Abstract][Full Text] [Related]
18. Platelets as a novel target for PPARgamma ligands : implications for inflammation, diabetes, and cardiovascular disease. Ray DM; Spinelli SL; O'Brien JJ; Blumberg N; Phipps RP BioDrugs; 2006; 20(4):231-41. PubMed ID: 16831022 [TBL] [Abstract][Full Text] [Related]